These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8480623)

  • 1. Reduction of left ventricular hypertrophy: how beneficial?
    Messerli FH; Aristizabal D; Soria F
    Am Heart J; 1993 May; 125(5 Pt 2):1520-4. PubMed ID: 8480623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy: should it be reduced?
    Messerli FH; Soria F; Aristizabal D
    Clin Cardiol; 1993 May; 16(5 Suppl 2):II15-20. PubMed ID: 8504585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of antihypertensive therapy: cardiac and extracardiac considerations.
    Messerli FH; Soria F
    Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive therapy on left ventricular hypertrophy and on its pathophysiologic sequelae.
    Messerli FH
    Blood Press Suppl; 1992; 1():35-6; discussion 37. PubMed ID: 1343271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy: impact of calcium channel blocker therapy.
    Messerli FH
    Am J Med; 1991 May; 90(5A):27S-31S. PubMed ID: 2039017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium channel blockade on cardiac repercussions of long-standing hypertension.
    Messerli FH
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S44-7. PubMed ID: 2468905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular dysrhythmias, left ventricular hypertrophy, and sudden death.
    Messerli FH; Soria F
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():557-63. PubMed ID: 7841089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death.
    Messerli FH; Grodzicki T
    Eur Heart J; 1992 Sep; 13 Suppl D():66-9. PubMed ID: 1396863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and left-ventricular hypertrophy.
    Messerli FH; Aepfelbacher FC
    Cardiol Clin; 1995 Nov; 13(4):549-57. PubMed ID: 8565018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.
    Kaplinsky E
    Cardiovasc Drugs Ther; 1994 Aug; 8 Suppl 3():549-56. PubMed ID: 7841088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and sudden cardiac death.
    Messerli FH
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):181S-188S. PubMed ID: 10619570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt sensitivity and left ventricular hypertrophy.
    Coca A; De la Sierra A
    Adv Exp Med Biol; 1997; 432():91-101. PubMed ID: 9433515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and reduction of left ventricular hypertrophy in the elderly.
    Lavie CJ; Milani RV; Messerli FH
    Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy: an independent risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S59-66; discussion S66-7. PubMed ID: 1726010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a reduction in left ventricular hypertrophy reduce cardiovascular morbidity and mortality?
    Messerli FH; Soria F
    Drugs; 1992; 44 Suppl 1():141-6. PubMed ID: 1283578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M; Motz WH; Schwartzkopf B; Strauer BE
    Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.